missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Trastuzumab Recombinant Human Monoclonal Antibody, Invitrogen™
Human Recombinant Monoclonal Antibody
Marque: Invitrogen MA542305
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Trastuzumab with the brand name Herceptin, is an FDA-approved drug for HER2-targeted therapy for breast cancer. It is a recombinant humanized monoclonal antibody (IgG1 kappa). Trastuzumab binds to HER2 receptor present on the surface of HER2-positive tumour cells and suppresses the cells growth and proliferation.
Spécification
| Trastuzumab | |
| Recombinant Monoclonal | |
| Unconjugated | |
| Herceptin; Metastatic lymph node gene 19 | |
| Human ERBB2 | |
| 100 μg | |
| Primary | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| Liquid | |
| Chemical |
| ELISA, SDS-Page | |
| 2.6 mg/mL | |
| PBS with no preservative; pH 7.4 | |
| Human | |
| Protein A | |
| RUO | |
| Chemical | |
| Antibody | |
| IgG1 |